Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Diagnostic accuracy of two commercial SARS-CoV-2 Antigen-detecting rapid tests at the point of care in community-based testing centers

Alice Berger, Marie Therese Ngo Nsoga, Francisco Javier Perez-Rodriguez, Yasmine Abi Aad, Pascale Sattonnet-Roche, Angèle Gayet-Ageron, Cyril Jaksic, Giulia Torriani, Erik Boehm, Ilona Kronig, Jilian A. Sacks, Margaretha de Vos, Frédérique Jacquerioz Bausch, François Chappuis, Laurent Kaiser, Manuel Schibler, Isabella Eckerle, for the Geneva Centre for Emerging Viral Diseases
doi: https://doi.org/10.1101/2020.11.20.20235341
Alice Berger
1Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie Therese Ngo Nsoga
1Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisco Javier Perez-Rodriguez
2Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasmine Abi Aad
1Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascale Sattonnet-Roche
2Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angèle Gayet-Ageron
3CRC & Division of Clinical-Epidemiology, Department of Health and Community Medicine, University of Geneva & University Hospitals of Geneva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cyril Jaksic
3CRC & Division of Clinical-Epidemiology, Department of Health and Community Medicine, University of Geneva & University Hospitals of Geneva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giulia Torriani
4Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Boehm
1Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilona Kronig
1Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jilian A. Sacks
5Foundation for Innovative New Diagnostics, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaretha de Vos
5Foundation for Innovative New Diagnostics, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frédérique Jacquerioz Bausch
6Department of Primary Care, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Chappuis
6Department of Primary Care, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Kaiser
1Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland
2Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland
7Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Schibler
1Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland
2Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland
7Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabella Eckerle
1Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland
2Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland
7Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: isabella.eckerle@unige.ch
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Antigen-detecting rapid diagnostic tests for SARS-CoV-2 offer new opportunities for the quick and laboratory-independent identification of infected individuals for control of the SARS-CoV-2 pandemic.

Methods We performed a prospective, single-center, point of care validation of two antigen-detecting rapid diagnostic tests (Ag-RDT) in comparison to RT-PCR on nasopharyngeal swabs.

Findings Between October 9th and 23rd, 2020, 1064 participants were enrolled. The Panbio™Covid-19 Ag Rapid Test device (Abbott) was validated in 535 participants, with 106 positive Ag-RDT results out of 124 positive RT-PCR individuals, yielding a sensitivity of 85.5% (95% CI: 78.0–91.2). Specificity was 100.0% (95% CI: 99.1–100) in 411 RT-PCR negative individuals. The Standard Q Ag-RDT (SD Biosensor, Roche) was validated in 529 participants, with 170 positive Ag-RDT results out of 191 positive RT-PCR individuals, yielding a sensitivity of 89.0% (95%CI: 83.7–93.1). One false positive result was obtained in 338 RT-PCR negative individuals, yielding a specificity of 99.7% (95%CI: 98.4–100). For individuals presenting with fever 1-5 days post symptom onset, combined Ag-RDT sensitivity was above 95%.

Interpretation We provide an independent validation of two widely available commercial Ag-RDTs, both meeting WHO criteria of ≥80% sensitivity and ≥97% specificity. Although less sensitive than RT-PCR, these assays could be beneficial due to their rapid results, ease of use, and independence from existing laboratory structures. Testing criteria focusing on patients with typical symptoms in their early symptomatic period onset could further increase diagnostic value.

Funding Foundation of Innovative Diagnostics (FIND), Fondation privée des HUG, Pictet Charitable Foundation.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding. Foundation of Innovative Diagnostics (FIND), Fondation privee des HUG, Pictet Charitable Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Cantonal ethics committee (Nr. 2020-02323). All study participants and/or their legal guardians provided written informed consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Original data are available upon request according to the regulations of the ethical approval.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 23, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Diagnostic accuracy of two commercial SARS-CoV-2 Antigen-detecting rapid tests at the point of care in community-based testing centers
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Diagnostic accuracy of two commercial SARS-CoV-2 Antigen-detecting rapid tests at the point of care in community-based testing centers
Alice Berger, Marie Therese Ngo Nsoga, Francisco Javier Perez-Rodriguez, Yasmine Abi Aad, Pascale Sattonnet-Roche, Angèle Gayet-Ageron, Cyril Jaksic, Giulia Torriani, Erik Boehm, Ilona Kronig, Jilian A. Sacks, Margaretha de Vos, Frédérique Jacquerioz Bausch, François Chappuis, Laurent Kaiser, Manuel Schibler, Isabella Eckerle, for the Geneva Centre for Emerging Viral Diseases
medRxiv 2020.11.20.20235341; doi: https://doi.org/10.1101/2020.11.20.20235341
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Diagnostic accuracy of two commercial SARS-CoV-2 Antigen-detecting rapid tests at the point of care in community-based testing centers
Alice Berger, Marie Therese Ngo Nsoga, Francisco Javier Perez-Rodriguez, Yasmine Abi Aad, Pascale Sattonnet-Roche, Angèle Gayet-Ageron, Cyril Jaksic, Giulia Torriani, Erik Boehm, Ilona Kronig, Jilian A. Sacks, Margaretha de Vos, Frédérique Jacquerioz Bausch, François Chappuis, Laurent Kaiser, Manuel Schibler, Isabella Eckerle, for the Geneva Centre for Emerging Viral Diseases
medRxiv 2020.11.20.20235341; doi: https://doi.org/10.1101/2020.11.20.20235341

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (940)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (418)
  • Epidemiology (8967)
  • Forensic Medicine (4)
  • Gastroenterology (417)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1320)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (211)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10764)
  • Intensive Care and Critical Care Medicine (570)
  • Medical Education (199)
  • Medical Ethics (52)
  • Nephrology (221)
  • Neurology (1815)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1891)
  • Public and Global Health (4107)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (361)
  • Respiratory Medicine (547)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (206)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)